ICOSAVAX, INC. Net Income
ICOSAVAX, INC. reported Net Income of -$22.04 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2023-11-14
- ICOSAVAX, INC. net income (loss) attributable to parent for the quarter ending 2023-09-30 was -$22.04M.
- ICOSAVAX, INC. net income (loss) attributable to parent for the quarter ending 2023-06-30 was -$26.50M.
- ICOSAVAX, INC. net income (loss) attributable to parent for the quarter ending 2023-03-31 was -$24.56M.
- ICOSAVAX, INC. net income (loss) attributable to parent for the quarter ending 2022-12-31 was -$23.61M.
- ICOSAVAX, INC. net income (loss) attributable to parent for fiscal 2022 was -$91.76M.
- ICOSAVAX, INC. net income (loss) attributable to parent for fiscal 2021 was -$66.97M.
- ICOSAVAX, INC. net income (loss) attributable to parent for fiscal 2020 was -$18.85M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$22.04M 10-Q · filed 2023-11-14 | -$48.54M derived: sum of 2 quarters · filed 2023-11-14 | -$73.10M 10-Q · filed 2023-11-14 | -$96.71M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | -$26.50M 10-Q · filed 2023-11-14 | -$51.06M 10-Q · filed 2023-08-14 | -$74.67M derived: sum of 3 quarters · filed 2023-11-14 | -$96.65M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | -$24.56M 10-Q · filed 2023-11-14 | -$48.17M derived: sum of 2 quarters · filed 2023-11-14 | -$70.15M derived: sum of 3 quarters · filed 2023-11-14 | -$92.79M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | -$23.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$45.59M derived: sum of 2 quarters · filed 2023-11-14 | -$68.22M derived: sum of 3 quarters · filed 2023-11-14 | -$91.76M 10-K · filed 2023-03-30 |
| 2022-09-30 | -$21.98M 10-Q · filed 2023-11-14 | -$44.61M derived: sum of 2 quarters · filed 2023-11-14 | -$68.14M 10-Q · filed 2023-11-14 | -$86.33M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$22.64M 10-Q · filed 2023-11-14 | -$46.17M 10-Q · filed 2023-08-14 | -$64.35M derived: sum of 3 quarters · filed 2023-11-14 | -$98.74M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-03-31 | -$23.53M 10-Q · filed 2023-11-14 | -$41.72M derived: sum of 2 quarters · filed 2023-11-14 | -$76.10M derived: sum of 3 quarters · filed 2023-11-14 | -$84.65M derived: sum of 4 quarters · filed 2023-11-14 |
| 2021-12-31 | -$18.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$52.57M derived: sum of 2 quarters · filed 2023-03-30 | -$61.12M derived: sum of 3 quarters · filed 2023-03-30 | -$66.97M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$34.39M 10-Q · filed 2022-11-14 | -$42.94M derived: sum of 2 quarters · filed 2022-11-14 | -$48.79M 10-Q · filed 2022-11-14 | -$53.40M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$8.55M 10-Q · filed 2022-11-14 | -$14.40M 10-Q · filed 2022-08-15 | -$19.01M derived: sum of 3 quarters · filed 2022-11-14 | -$24.59M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-03-31 | -$5.85M 10-Q · filed 2022-11-14 | -$10.46M derived: sum of 2 quarters · filed 2022-11-14 | -$16.04M derived: sum of 3 quarters · filed 2022-11-14 | -$21.23M derived: sum of 4 quarters · filed 2022-11-14 |
| 2020-12-31 | -$4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$10.19M derived: sum of 2 quarters · filed 2022-03-30 | -$15.38M derived: sum of 3 quarters · filed 2022-03-30 | -$18.85M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$5.58M 10-Q · filed 2021-11-15 | -$10.78M derived: sum of 2 quarters · filed 2021-11-15 | -$14.25M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$5.20M 10-Q · filed 2021-09-13 | -$8.67M 10-Q · filed 2021-09-13 |